Proactive Therapeutic Drug Monitoring of Adalimumab Is Associated with Better Long-term Outcomes Compared with Standard of Care in Patients with Inflammatory Bowel Disease
Konstantinos Papamichael, Anna Juncadella, Danny Wong, Shana Rakowsky, Lindsey A. Sattler, James P. Campbell, Byron P. Vaughn, Adam S. Cheifetz
Dive into the research topics of 'Proactive Therapeutic Drug Monitoring of Adalimumab Is Associated with Better Long-term Outcomes Compared with Standard of Care in Patients with Inflammatory Bowel Disease'. Together they form a unique fingerprint.